ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors

Catherine C. Roberts, Mark J. Kransdorf, Francesca D. Beaman, Ronald S. Adler, Behrang Amini, Marc Appel, Stephanie A. Bernard, Ian Blair Fries, Isabelle M. Germano, Bennett Steven Greenspan, Langston T. Holly, Charlotte D. Kubicky, Simon Shek-Man Lo, Timothy J. Mosher, Andrew E. Sloan, Michael J. Tuite, Eric A. Walker, Robert J. Ward, Daniel E. Wessell, Barbara N. Weissman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc bone scan, and ultrasound. Clinical scenarios reviewed include evaluation for metastatic disease to the lung in low- and high-risk patients, for osseous metastatic disease in asymptomatic and symptomatic patients, for local recurrence of osseous tumors with and without significant hardware present, and for local recurrence of soft tissue tumors. The timing for follow-up of pulmonary metastasis surveillance is also reviewed. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)389-400
Number of pages12
JournalJournal of the American College of Radiology
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Guidelines
Asymptomatic Diseases
Recurrence
Neoplasms
Fluorodeoxyglucose F18
Expert Testimony
Radiography
Lung Diseases
Neoplasm Metastasis
Bone and Bones
Lung
Therapeutics

Keywords

  • Appropriateness Criteria
  • aggressive
  • follow-up
  • imaging
  • malignant
  • musculoskeletal tumors

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Roberts, C. C., Kransdorf, M. J., Beaman, F. D., Adler, R. S., Amini, B., Appel, M., ... Weissman, B. N. (2016). ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors. Journal of the American College of Radiology, 13(4), 389-400. https://doi.org/10.1016/j.jacr.2015.12.019

ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors. / Roberts, Catherine C.; Kransdorf, Mark J.; Beaman, Francesca D.; Adler, Ronald S.; Amini, Behrang; Appel, Marc; Bernard, Stephanie A.; Fries, Ian Blair; Germano, Isabelle M.; Greenspan, Bennett Steven; Holly, Langston T.; Kubicky, Charlotte D.; Shek-Man Lo, Simon; Mosher, Timothy J.; Sloan, Andrew E.; Tuite, Michael J.; Walker, Eric A.; Ward, Robert J.; Wessell, Daniel E.; Weissman, Barbara N.

In: Journal of the American College of Radiology, Vol. 13, No. 4, 01.04.2016, p. 389-400.

Research output: Contribution to journalArticle

Roberts, CC, Kransdorf, MJ, Beaman, FD, Adler, RS, Amini, B, Appel, M, Bernard, SA, Fries, IB, Germano, IM, Greenspan, BS, Holly, LT, Kubicky, CD, Shek-Man Lo, S, Mosher, TJ, Sloan, AE, Tuite, MJ, Walker, EA, Ward, RJ, Wessell, DE & Weissman, BN 2016, 'ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors', Journal of the American College of Radiology, vol. 13, no. 4, pp. 389-400. https://doi.org/10.1016/j.jacr.2015.12.019
Roberts, Catherine C. ; Kransdorf, Mark J. ; Beaman, Francesca D. ; Adler, Ronald S. ; Amini, Behrang ; Appel, Marc ; Bernard, Stephanie A. ; Fries, Ian Blair ; Germano, Isabelle M. ; Greenspan, Bennett Steven ; Holly, Langston T. ; Kubicky, Charlotte D. ; Shek-Man Lo, Simon ; Mosher, Timothy J. ; Sloan, Andrew E. ; Tuite, Michael J. ; Walker, Eric A. ; Ward, Robert J. ; Wessell, Daniel E. ; Weissman, Barbara N. / ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors. In: Journal of the American College of Radiology. 2016 ; Vol. 13, No. 4. pp. 389-400.
@article{f44b6fb934f64d0087da63c5c1b541d8,
title = "ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors",
abstract = "Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc bone scan, and ultrasound. Clinical scenarios reviewed include evaluation for metastatic disease to the lung in low- and high-risk patients, for osseous metastatic disease in asymptomatic and symptomatic patients, for local recurrence of osseous tumors with and without significant hardware present, and for local recurrence of soft tissue tumors. The timing for follow-up of pulmonary metastasis surveillance is also reviewed. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.",
keywords = "Appropriateness Criteria, aggressive, follow-up, imaging, malignant, musculoskeletal tumors",
author = "Roberts, {Catherine C.} and Kransdorf, {Mark J.} and Beaman, {Francesca D.} and Adler, {Ronald S.} and Behrang Amini and Marc Appel and Bernard, {Stephanie A.} and Fries, {Ian Blair} and Germano, {Isabelle M.} and Greenspan, {Bennett Steven} and Holly, {Langston T.} and Kubicky, {Charlotte D.} and {Shek-Man Lo}, Simon and Mosher, {Timothy J.} and Sloan, {Andrew E.} and Tuite, {Michael J.} and Walker, {Eric A.} and Ward, {Robert J.} and Wessell, {Daniel E.} and Weissman, {Barbara N.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.jacr.2015.12.019",
language = "English (US)",
volume = "13",
pages = "389--400",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors

AU - Roberts, Catherine C.

AU - Kransdorf, Mark J.

AU - Beaman, Francesca D.

AU - Adler, Ronald S.

AU - Amini, Behrang

AU - Appel, Marc

AU - Bernard, Stephanie A.

AU - Fries, Ian Blair

AU - Germano, Isabelle M.

AU - Greenspan, Bennett Steven

AU - Holly, Langston T.

AU - Kubicky, Charlotte D.

AU - Shek-Man Lo, Simon

AU - Mosher, Timothy J.

AU - Sloan, Andrew E.

AU - Tuite, Michael J.

AU - Walker, Eric A.

AU - Ward, Robert J.

AU - Wessell, Daniel E.

AU - Weissman, Barbara N.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc bone scan, and ultrasound. Clinical scenarios reviewed include evaluation for metastatic disease to the lung in low- and high-risk patients, for osseous metastatic disease in asymptomatic and symptomatic patients, for local recurrence of osseous tumors with and without significant hardware present, and for local recurrence of soft tissue tumors. The timing for follow-up of pulmonary metastasis surveillance is also reviewed. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

AB - Appropriate imaging modalities for the follow-up of malignant or aggressive musculoskeletal tumors include radiography, MRI, CT, 18 F-2-fluoro-2-deoxy-D-glucose PET/CT, 99m Tc bone scan, and ultrasound. Clinical scenarios reviewed include evaluation for metastatic disease to the lung in low- and high-risk patients, for osseous metastatic disease in asymptomatic and symptomatic patients, for local recurrence of osseous tumors with and without significant hardware present, and for local recurrence of soft tissue tumors. The timing for follow-up of pulmonary metastasis surveillance is also reviewed. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

KW - Appropriateness Criteria

KW - aggressive

KW - follow-up

KW - imaging

KW - malignant

KW - musculoskeletal tumors

UR - http://www.scopus.com/inward/record.url?scp=84959088007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959088007&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2015.12.019

DO - 10.1016/j.jacr.2015.12.019

M3 - Article

VL - 13

SP - 389

EP - 400

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

SN - 1558-349X

IS - 4

ER -